Charles River Executive and Leadership Team

Birgit Girshick, the Chief Executive Officer at Charles River, directs the overarching strategic vision for the entire organization. Overseeing the global portfolio of research and safety assessment services, the Chief Executive Officer ensures alignment between scientific capabilities and client needs across the drug development lifecycle. This leadership role involves managing complex relationships with regulatory bodies and internal stakeholders to maintain market dominance. By optimizing the end-to-end service model, Birgit Girshick accelerates the delivery of critical medical devices and chemical solutions to international markets. The Chief Executive Officer maintains a focus on operational efficiency and long-term growth, ensuring the company remains a leader in the life sciences sector. Through rigorous oversight of discovery and manufacturing initiatives, Girshick drives the organizational mission to support patients worldwide with high-quality, reliable scientific data and manufacturing excellence.

Glenn Coleman, the Chief Financial Officer at Charles River, oversees the financial health and capital allocation strategies for the entire organization. Managing global fiscal operations, the Chief Financial Officer ensures that investments in research, discovery, and manufacturing align with long-term growth targets. This leadership role involves directing financial planning, reporting, and investor relations to maintain market confidence. By optimizing the capital structure, Glenn Coleman supports the expansion of the company's end-to-end portfolio across North American and international markets. The Chief Financial Officer works closely with the Board to assess risks and identify opportunities for strategic acquisitions that enhance the service offerings. Through rigorous financial oversight, Coleman secures the resources necessary for scientific advancement and infrastructure development. This role remains central to the company's ability to deliver consistent value while accelerating the development of life-saving drugs and medical devices.

Peter Y., the Divisional Chief Financial Officer & Vice President, Finance at Charles River, manages the financial performance of specific business units within the organization. Overseeing divisional budgets and cost structures, the Divisional Chief Financial Officer & Vice President, Finance ensures that operational spending supports the company's research and safety assessment goals. This role involves analyzing market trends to improve profitability within the manufacturing and commercialization segments. By providing granular financial insights, Peter Y. enables divisional leaders to make data-driven decisions that enhance efficiency. The Divisional Chief Financial Officer & Vice President, Finance coordinates with corporate finance to ensure consistency in reporting and compliance across all regional operations. Through the management of divisional assets, Y. supports the broader mission of accelerating drug development. This position requires a focus on fiscal discipline and strategic resource allocation to maintain the company's competitive edge in the life sciences market.

Stacey Pauze, the Chief of Staff at Charles River, manages the executive office operations and facilitates cross-functional collaboration across the enterprise. Coordinating high-priority initiatives, the Chief of Staff ensures that strategic objectives receive consistent attention from leadership teams. This role involves streamlining communication between the C-suite and various business units to enhance organizational agility. By monitoring key performance indicators, Stacey Pauze supports the execution of corporate goals related to drug discovery and safety assessment. The Chief of Staff maintains a focus on internal alignment, ensuring that resources support the most critical research and development projects. Through the management of executive workflows, Pauze enables the leadership team to focus on market expansion and scientific innovation. This position requires deep integration with all departments to ensure that the company maintains its reputation for excellence in the global life sciences industry.

Mark Mintz, the Executive VP & Global Chief Information Officer, Shared Services at Charles River, directs the digital transformation and information technology infrastructure for the company. Overseeing global data systems and cybersecurity, the Executive VP & Global Chief Information Officer, Shared Services ensures that the technological backbone supports complex research and manufacturing processes. This role involves implementing scalable software solutions that enhance collaboration across international research facilities. By optimizing shared services, Mark Mintz drives operational efficiency and data integrity throughout the drug discovery lifecycle. The Executive VP & Global Chief Information Officer, Shared Services works with other leaders to integrate advanced analytics into the company's service portfolio. Through the management of enterprise-wide IT initiatives, Mintz enables the organization to maintain high standards of security and innovation. This position remains critical to the company's ability to provide reliable, technology-driven solutions to clients in the pharmaceutical and chemical industries.

Matthew Hewitt, the Vice President, Chief Technology Officer Manufacturing Business Division at Charles River, leads the technological advancements within the manufacturing sector of the company. Overseeing the development of innovative manufacturing processes, the Vice President, Chief Technology Officer Manufacturing Business Division ensures that the company maintains state-of-the-art capabilities for medical device and drug production. This role involves integrating new technologies to improve production speed and quality control. By driving technical excellence, Matthew Hewitt supports the company's mission to provide end-to-end solutions for clients from discovery to commercialization. The Vice President, Chief Technology Officer Manufacturing Business Division collaborates with research teams to translate scientific breakthroughs into scalable manufacturing workflows. Through the management of technical resources, Hewitt ensures that the division meets the highest regulatory standards. This position requires a focus on continuous improvement and the adoption of cutting-edge manufacturing techniques to support global market demands.

Victoria Creamer, the Chief People Officer at Charles River, directs the human resources strategy and talent management initiatives for the global workforce. Overseeing recruitment, professional development, and organizational culture, the Chief People Officer ensures that the company attracts and retains the scientific talent necessary for drug discovery and safety assessment. This role involves building programs that foster innovation and employee engagement across all international locations. By optimizing talent acquisition, Victoria Creamer supports the company's ability to scale its research and manufacturing operations. The Chief People Officer works with leadership to align workforce capabilities with the evolving needs of the life sciences industry. Through the management of human capital, Creamer drives the organizational mission to support patients by empowering the people who develop medical solutions. This position requires a focus on diversity, equity, and inclusion to maintain a high-performing, collaborative environment that drives scientific progress.

Amy Cianciaruso, the Corporate Senior Vice President, Chief Communications Officer at Charles River, manages the internal and external communication strategies for the organization. Overseeing brand reputation and public relations, the Corporate Senior Vice President, Chief Communications Officer ensures that the company's mission to accelerate drug development is clearly articulated to stakeholders and the public. This role involves directing corporate messaging and media engagement to maintain the company's position as a leader in the life sciences sector. By optimizing communication channels, Amy Cianciaruso supports the company's efforts to build trust with clients and regulatory bodies. The Corporate Senior Vice President, Chief Communications Officer works with executive leadership to manage crisis communications and promote corporate social responsibility initiatives. Through the management of brand identity, Cianciaruso ensures that the company's values are reflected in all public interactions. This position remains essential for maintaining the company's global reputation and market influence.

Ameer Badi, the Doctror at Charles River, provides specialized scientific expertise to support the company's research and safety assessment services. Overseeing technical evaluations and clinical data analysis, the Doctror ensures that all scientific outputs meet the rigorous standards required for drug and medical device development. This role involves collaborating with research teams to solve complex problems during the discovery and commercialization phases. By applying deep scientific knowledge, Ameer Badi drives the accuracy and reliability of the company's end-to-end portfolio. The Doctror works with regulatory advisors to ensure that all findings comply with international health standards. Through the management of scientific projects, Badi supports the company's mission to accelerate the delivery of medical solutions to patients. This position requires a focus on precision and innovation to maintain the company's reputation for scientific excellence in the global market. Badi remains a key contributor to the company's research capabilities.